Immunovant Inc (IMVT)
30.51
+1.23
(+4.20%)
USD |
NASDAQ |
Oct 04, 16:00
30.56
+0.05
(+0.16%)
After-Hours: 20:00
Immunovant Shareholders Equity (Annual): 617.76M for March 31, 2024
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| March 31, 2024 | 617.76M |
| March 31, 2023 | 362.49M |
| March 31, 2022 | 469.82M |
| Date | Value |
|---|---|
| March 31, 2021 | 391.48M |
| March 31, 2020 | 94.07M |
| December 31, 2018 | 0.0246M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
94.07M
Minimum
2020
617.76M
Maximum
2024
387.12M
Average
391.48M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Perspective Therapeutics Inc | 75.18M |
| Electromed Inc | 44.54M |
| Xtant Medical Holdings Inc | 51.35M |
| Myomo Inc | 8.989M |
| Catheter Precision Inc | 21.19M |